Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Al-Sarraf

Showing results (61-70 of 145) with videos related to

Pageof 15
Sort By:
American Journal of Clinical Oncology|October 1, 1986
High-dose ketoconazole therapy in patients with metastatic prostate cancerE Tapazoglou, M G Subramanian, M Al-Sarraf, et al.
American Journal of Clinical Oncology|October 1, 1987
Pilot study of combination 5-fluorouracil, cisdiamminedichloroplatinum II, and radiation therapy for grade III and IV astrocytomasD A Decker, J Kinzie, R Evans, et al.
Cancer|August 15, 1983
Chemotherapy for nasopharyngeal carcinoma. A ten-year experienceD A Decker, A Drelichman, M Al-Sarraf, et al.
Cancer|December 15, 1983
Hypercalcemia in head and neck carcinoma. Incidence and prognosisC Won, D A Decker, A Drelichman, et al.
Cancer|October 1, 1979
The value of serial carcinoembryonic antigen (CEA) in predicting response rate and survival of patients with gastrointestinal cancer treated with chemotherapyM Al-Sarraf, L Baker, R W Talley, et al.
Oncology|January 1, 1973
The incidence and significance of Australia antigen in cancer patientsM al-Sarraf, K Kithier, S Sardesai, et al.
Cancer|March 1, 1984
Computerized bone scan. A potentially useful technique to measure response in prostatic carcinomaA Drelichman, D A Decker, M Al-Sarraf, et al.
Archives of Otolaryngology--Head & Neck Surgery|March 1, 1989
Combined therapy for resectable head and neck cancer. A phase 3 intergroup studyD E Schuller, G Laramore, M Al-Sarraf, et al.
Journal of Neuro-Oncology|January 1, 1985
Phase II study of aziridinylbenzoquinone (AZQ: NSC-182986) in the treatment of malignant gliomas recurrent after radiation. Preliminary reportD A Decker, M Al Sarraf, C Kresge, et al.
American Journal of Clinical Oncology|October 1, 1988
Evaluation of high-dose cisplatin and 5-FU infusion as initial therapy in advanced head and neck cancerJ A Kish, J F Ensley, J R Jacobs, et al.
Pageof 15

Showing results (61-70 of 145) with videos related to

Sort By:
Pageof 15
American Journal of Clinical Oncology|October 1, 1986
High-dose ketoconazole therapy in patients with metastatic prostate cancerE Tapazoglou, M G Subramanian, M Al-Sarraf, et al.
American Journal of Clinical Oncology|October 1, 1987
Pilot study of combination 5-fluorouracil, cisdiamminedichloroplatinum II, and radiation therapy for grade III and IV astrocytomasD A Decker, J Kinzie, R Evans, et al.
Cancer|August 15, 1983
Chemotherapy for nasopharyngeal carcinoma. A ten-year experienceD A Decker, A Drelichman, M Al-Sarraf, et al.
Cancer|December 15, 1983
Hypercalcemia in head and neck carcinoma. Incidence and prognosisC Won, D A Decker, A Drelichman, et al.
Cancer|October 1, 1979
The value of serial carcinoembryonic antigen (CEA) in predicting response rate and survival of patients with gastrointestinal cancer treated with chemotherapyM Al-Sarraf, L Baker, R W Talley, et al.
Oncology|January 1, 1973
The incidence and significance of Australia antigen in cancer patientsM al-Sarraf, K Kithier, S Sardesai, et al.
Cancer|March 1, 1984
Computerized bone scan. A potentially useful technique to measure response in prostatic carcinomaA Drelichman, D A Decker, M Al-Sarraf, et al.
Archives of Otolaryngology--Head & Neck Surgery|March 1, 1989
Combined therapy for resectable head and neck cancer. A phase 3 intergroup studyD E Schuller, G Laramore, M Al-Sarraf, et al.
Journal of Neuro-Oncology|January 1, 1985
Phase II study of aziridinylbenzoquinone (AZQ: NSC-182986) in the treatment of malignant gliomas recurrent after radiation. Preliminary reportD A Decker, M Al Sarraf, C Kresge, et al.
American Journal of Clinical Oncology|October 1, 1988
Evaluation of high-dose cisplatin and 5-FU infusion as initial therapy in advanced head and neck cancerJ A Kish, J F Ensley, J R Jacobs, et al.
Pageof 15